Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 560, pseudogene (RN7SL560P) is a pseudogene related to the functional 7SL RNA, a structural RNA that is the central RNA component of the eukaryotic signal recognition particle (SRP), essential for the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[1][3][6]. However, RN7SL560P is a pseudogene, meaning it is a non-functional, often truncated or mutated copy of the parental 7SL RNA gene, and does not produce functional RNA or protein[6]. The vast majority of 7SL RNA pseudogenes in the human genome are believed to have no direct biological activity, though pseudogenes in general can sometimes act as competitive endogenous RNAs (ceRNAs) or miRNA sponges, influencing gene regulation indirectly[2]. There is no evidence or literature suggesting that RN7SL560P serves as a therapeutic target or is directly linked to disease mechanisms. Its main relevance is as a genomic relic of retrotransposition processes and molecular evolution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 560, pseudogene (RN7SL560P).